[1
]
Department of Obstetrics and Gynecology, Seoul National University College of Medicine,
Seoul, Republic of Korea.
[2
]
Center for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center,
Goyang, Republic of Korea.
[3
]
Department of Cancer Control and Population Health, National Cancer Center Graduate
School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea.
[4
]
Department of Medical Oncology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek
Hospital, Amsterdam, the Netherlands.
[5
]
Department of Gynecology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek
Hospital, Amsterdam, the Netherlands.
[6
]
Division of Gynecologic Oncology, Obstetrics and Gynecology, Irvine Medical Center,
University of California, California, USA.
[7
]
Department of Surgery and Cancer, Gynaecologic Oncology, Imperial College London,
London, UK.
[8
]
Center for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center,
Goyang, Republic of Korea; Department of Cancer Control and Policy, National Cancer
Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang,
Republic of Korea; Rare & Pediatric Cancer Branch and Immuno-oncology Branch, Division
of Rare and Refractory Cancer, Research Institute and Hospital, National Cancer Center,
Goyang, Republic of Korea; Center for Clinical Trial, Research Institute and Hospital,
National Cancer Center, Goyang, Republic of Korea. Electronic address: mclim@ncc.re.kr.